Results

Total Results: 7,201 records

Showing results for "healthcare cost and utilization".

7081. Trauma-Interventions-Maltreatment-Child Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_executive.pdf
      April 01, 2013 - analytical methods, reports low attrition, and describes methods and outcomes clearly and precisely … 0.80; Cohen’s h = 0.20, 0.50, and 0.80; and correlation coefficient r = 0.10, 0.30, and 0.50, respectively … structure, service definitions, utilization management, treatment authorization, and claims submission … and authorization. … and Quality.

7082. MEPS Annual Methodology Report - Medical Provider Component (MEPS-MPC)
      meps.ahrq.gov/data_files/publications/annual_contractor_report/mpc_ann_cntrct_methrpt.shtml
      May 01, 2025 - for services, and on the cost and scope of health insurance covering U.S. workers. … For Non-Pharmacy pairs, the file includes pairs with eligible dates of utilization (that is, calendar … Department of Health and Human Services and AHRQ. … All High and Medium priority nodes and subsamples of the Low and Extra Low priority nodes were fielded … OBD and SBD providers.

7083. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
      March 02, 2020 - Main Outcomes and Measures: Mortality, morbidity, quality of life, screening and treatment harms, and … Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. … Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection. … Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously … early and advanced fibrosis treated with ledipasvir and sofosbuvir.

7084. Optimal Methods for Notifying Clinicians about Epilepsy Surgery Patients - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs024977-dexheimer-final-report-2018.pdf
      January 01, 2018 - The sensitivity, specificity, positive- and negative-predictive value, and F1 score of the algorithm … -42 and can improve compliance and patient outcomes.43 Support for the Use of the Decision Support … This research will inform future Health IT research and drive successful implementations of NLP and … caregivers, and a decreased treatment cost.52 The resulting integrated system can be generalizable … ) and elected to be re-alerted (55/60 [90%] and 60/61 [95%], respectively; p = 0.80).

7085. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTJ_Zj3TAkhx45wWUDtNyt
      May 01, 2021 - men of all races and ethnicities, and especially among Black and Hispanic adults, who have the highest … prevalence of CVD and the lowest utilization of statins, respectively. … risk prediction in all racial and ethnic and socioeco- nomic groups in the Research Needs and Gaps section … public comment of the draft evidence report and draft recommendation statement, and the writing and … , 1980 and 2018.

7086. Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/_2-KL_eHkuBhbGrzcAHsB-
      June 01, 2022 - , and benefits and harms of treatment of MDD and suicide risk in children and adolescents that would … Rates of suicide attempts and deaths vary by sex, age, and race and ethnicity.1,2 USPSTF Assessment … Clinician Summary: Screening for Depression and Suicide Risk in Children and Adolescents Children and … harms of screening, accuracy of screening, and ben- efits and harms of treatment of MDD and suicide … Service utilization for lifetime mental disorders in US adolescents: results of the National Comorbidity

7087. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - Arthritis and Rheumatism, Clinical Rheumatology, Journal of Clinical Rheumatology, and Rheumatology … The rate and type of adverse events were generally similar between intervention and placebo groups, … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … Prince, 201120 Cohort, parents and data from the arthritis and biologicals in children- register … and 90 response rates respectively were 94.7%, 94.7%,57.9% and 10.5% at week 12 and 100%, 94.1%,

7088. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - Arthritis and Rheumatism, Clinical Rheumatology, Journal of Clinical Rheumatology, and Rheumatology … The rate and type of adverse events were generally similar between intervention and placebo groups, … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … Prince, 201120 Cohort, parents and data from the arthritis and biologicals in children- register … and 90 response rates respectively were 94.7%, 94.7%,57.9% and 10.5% at week 12 and 100%, 94.1%,

7089. Hypertension-Pulmonary-Arterial Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
      April 01, 2013 - ultimately right heart failure and premature death.2 The causes of PAH are numerous and are listed … use of echocardiography and biomarkers affects decisionmaking and clinical outcomes. … and on intermediate-term (≤90 days) and long-term (>90 days) patient outcomes? … and specificity and associated confidence intervals and summary receiver operating characteristic … funding, one by private and industry funding, one by industry and “other” funding, and five did not

7090. Archived: Final Evidence Summary: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
      December 15, 2010 - gait and balance. … health outcomes (injury and fractures, quality of life, disability, and mortality). … Fall history is an independent predictor of adverse health outcomes and utilization in the elderly. … in community and emergency care settings: systematic review and meta-analysis. … handrails, and modifying the environment to improve mobility and safety.

7091. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
      February 18, 2020 - It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment … Statins reduce levels of total cholesterol and LDL-C and, to a lesser extent, triglycerides, and probably … adults 21 years and older on CVD-related morbidity and mortality; the benefits and harms of statin use … older and women 50 years and older without CVD risk factors and in adults of any age with CVD risk factors … public comment of the draft evidence report and draft recommendation statement, and the writing and

7092. Migraine-Prevention Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
      June 01, 2013 - We abstracted inclusion and exclusion criteria, drug regimen and doses, and patient characteristics … and standard deviations. … drug treatments and comparators and used the same definitions of the outcomes. … Impact of migraine and migraine therapy on productivity and quality of life. … Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands.

7093. Transcranial Doppler Ultrasonography Screening Among Children With Sickle Cell Anemia (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-139-fullreport.pdf
      May 01, 2017 - condition and burden of condition on children, family, and society (unrelated to cost) • Fiscal burden … • Relevance to the Early and Periodic Screening, Diagnostic and Treatment benefit in Medicaid (EPSDT … codes and dates. … Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. … Sickle cell disease and stroke.

7094. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
      January 01, 2015 - and specific combination therapies on intermediate outcomes (HbA1c and weight, particularly) and safety … Weight favors Met over DPP4 (and TZD and SU in previous review). GLP1 beats SU. … , and GLP1 agonists and SGLT2 inhibitors with weight loss. … and second reports. … and mortality.

7095. Archived: Final Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening-2009
      July 15, 2009 - Data Sources: MEDLINE® and the Cochrane Central Register of Controlled Trials and the Cochrane Database … in older persons and can affect the ability to live independently or increase the risk for falls and … Dana, and Ms. … , MPH, and the U.S. … ≤10 >0.1 and ≤2 Moderate >2 and ≤5 >0.2 and ≤0.5 Small or

7096. CAHPS Transcript: Strategies for Improving CAHPS Health Plan Survey Scores (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/20160413/hp-survey-strategies-webcast-transcript.pdf
      April 01, 2016 - And if that doesn’t work, log in and log back in. … And so what we decided to do is we really took advantage of the CAHPS Proxy, and we looked at that and … And so we’ve worked with our call center and we’ve partnered with them, and that’s exactly what we do … And it represents a number of new and unfamiliar systems, both for members and for the professionals, … ’s very high cost services, intensive service delivery when you look at what might be called high utilization

7097. Cancer-Pancreas Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
      September 01, 2014 - patients weigh the benefits and harms of these tests and allow patients and their providers to incorporate … MDCT and PET/CT. … , postprocedural pain, and puncture, perforation, and bleeding … , postprocedural pain, and puncture, perforation, and bleeding. … is largely institution-specific based on technology and resource availability and institution and

7098. Redesigning Systems To Improve Teamwork and Quality for Hospitalized Patients: RESET Project Implementation Guide (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reset-guide.pdf
      January 01, 2020 - RESET addresses and the expected benefit to patients and the organization. … in Appendices E and F … Compare and contrast the activities of the unit nurse and physician leader and make sure these leaders … team members and partner with patients and family members. … Patient activation and 30-day post-discharge hospital utilization.

7099. Methodology Report 2023 Data Collection (pdf file)
      meps.ahrq.gov/data_files/publications/annual_contractor_report/mpc_ann_cntrct_methrpt.pdf
      May 01, 2025 - for services, and on the cost and scope of health insurance covering U.S. … For Non-Pharmacy pairs, the file includes pairs with eligible dates of utilization (that is, calendar … Department of Health and Human Services and AHRQ. … All High and Medium priority nodes and subsamples of the Low and Extra Low priority nodes were fielded … inpatient stay (excluding first and last day); and c.

7100. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
      June 07, 2013 - Overall Benefits and Harms of OCs discussions and conclusions very clear and well-written FRN … Overall Benefits and Harms of OCs tables and figures are great: especially Fig 51/52 and Table … and cervical cancer, DVT, PE, stroke and MI. … Overall Benefits and Harms of OCs The conclusion section is weak and contradictory and leaves the … report and its methods and findings.